Versor Investments’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-17,857	Closed	-$1.4M	–	732
2025 Q2	$1.4M	Buy	17,857 +2,357	+15%	+$176K	0.25%	87
2025 Q1	$1.12M	Buy	+15,500	New	+$1.11M	0.18%	167
2024 Q4	–	Sell	-4,455	Closed	-$294K	–	822
2024 Q3	$294K	Buy	4,455 +2,255	+103%	+$164K	0.05%	595
2024 Q2	$203K	Sell	2,200 -4,300	-66%	-$381K	0.04%	658
2024 Q1	$621K	Buy	+6,500	New	+$546K	0.13%	269
2023 Q4	–	Sell	-4,496	Closed	-$311K	–	753
2023 Q3	$311K	Buy	4,496 +2,043	+83%	+$164K	0.06%	476
2023 Q2	$231K	Sell	2,453 -7,122	-74%	-$619K	0.04%	518
2023 Q1	$792K	Buy	+9,575	New	+$753K	0.1%	177
2022 Q2	–	Sell	-1,773	Closed	-$209K	–	834
2022 Q1	$209K	Buy	+1,773	New	+$199K	0.01%	573
2020 Q3	–	Sell	-8,448	Closed	-$584K	–	304
2020 Q2	$584K	Sell	8,448 -6,849	-45%	-$487K	0.06%	71
2020 Q1	$962K	Sell	15,297 -3,303	-18%	-$238K	0.06%	55
2019 Q4	$1.45M	Buy	+18,600	New	+$1.45M	0.07%	95